You just read:

FDA Joint Meeting of Advisory Committees Recommends Commitment to Higher Doses and Broader Access for Naloxone to Help in Fight Against Opioid Overdose

News provided by

Adapt Pharma

Oct 06, 2016, 09:00 ET